Long-term Safety and Efficacy Data with Inhaled Pirfenidone (AP01) in the ATLAS Open-label Extension Study Up to 240 Weeks

Tamera J. Corte, Sebastien Tilleux, Deepthi K. Nair, Felix A. Woodhead, Hao Bao, Craig S. Conoscenti, Howard M. Lazarus, Margaret L. Wilsher